Literature DB >> 31086724

Percutaneous Needle Fasciotomy for Dupuytren Contracture.

Joakim Strömberg1,2.   

Abstract

BACKGROUND: Percutaneous needle fasciotomy (PNF) is a minimally invasive treatment option for mild to moderate Dupuytren contractures in the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints, and the procedure requires limited resources. Multiple contractures can be treated during the same session, and the treatment is considerably easier for the patient and requires a minimum of rehabilitation compared with limited fasciectomy1. DESCRIPTION: PNF can be performed in a regular outpatient clinic in most cases. With the patient in a reclined position, the cord of the contracted joint is tensioned by passive extension and is divided percutaneously with a 25-gauge needle under local anesthesia. The immediate treatment effect in terms of reduction of the contracture is readily assessed, and PNF can be performed at additional levels if needed. ALTERNATIVES: Collagenase Clostridium histolyticum (CCH; Xiaflex).Total or partial fasciectomy.Dermofasciectomy.Amputation (in severe cases after multiple other procedures). RATIONALE: Local treatment with injection of CCH (Xiaflex) in the Dupuytren cord enables rupture of the cord similar to that after PNF2. Both CCH and PNF are minimally invasive treatments with obvious advantages compared with open surgery3, and they seem to have the same intermediate-term outcome4-6. However, CCH treatment is considerably more expensive than PNF and requires 2 visits by the patient to the outpatient clinic instead of 17. CCH has also been reported to have more complications than PNF2,8. Furthermore, multiple (>4) joint contractures9 can be treated by PNF at the same time. In the author's experience, even bilateral contractures can be treated at the same session if requested by the patient. As the number of patients treated with CCH and PNF has increased, there has been a corresponding decrease in more invasive procedures10; however, open surgery will probably always remain an option in more severe cases or as a secondary procedure after recurrence.

Entities:  

Year:  2019        PMID: 31086724      PMCID: PMC6485769          DOI: 10.2106/JBJS.ST.18.00047

Source DB:  PubMed          Journal:  JBJS Essent Surg Tech        ISSN: 2160-2204


  16 in total

1.  Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for dupuytren contracture.

Authors:  Neal C Chen; Melissa J Shauver; Kevin C Chung
Journal:  J Hand Surg Am       Date:  2011-10-05       Impact factor: 2.230

2.  One-year results of needle fasciotomy and collagenase injection in treatment of Dupuytren's contracture: A two-centre prospective randomized clinical trial.

Authors:  P Scherman; P Jenmalm; L B Dahlin
Journal:  J Hand Surg Eur Vol       Date:  2015-12-01

3.  Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy.

Authors:  Annet L van Rijssen; Hein Ter Linden; Paul M N Werker
Journal:  Plast Reconstr Surg       Date:  2012-02       Impact factor: 4.730

4.  Comparison of Treatment Outcome After Collagenase and Needle Fasciotomy for Dupuytren Contracture: A Randomized, Single-Blinded, Clinical Trial With a 1-Year Follow-Up.

Authors:  Joakim Strömberg; Allan Ibsen-Sörensen; Jan Fridén
Journal:  J Hand Surg Am       Date:  2016-07-27       Impact factor: 2.230

5.  Multi-needle aponeurotomy for advanced Dupuytren's disease: preliminary results of safety and efficacy (MNA 1 study).

Authors:  Johann Beaudreuil; Jean-Luc Lermusiaux; Jean-Pierre Teyssedou; Sophie Lahalle; Sandra Lasbleiz; Brigitte Bernabé; Henri Lellouche; Philippe Orcel; Thomas Bardin
Journal:  Joint Bone Spine       Date:  2011-02-25       Impact factor: 4.929

6.  Results of needle aponeurotomy for Dupuytren contracture in over 1,000 fingers.

Authors:  Gary M Pess; Rebecca M Pess; Rachel A Pess
Journal:  J Hand Surg Am       Date:  2012-04       Impact factor: 2.230

7.  Percutaneous needle fasciotomy in dupuytren's disease.

Authors:  A L van Rijssen; P M N Werker
Journal:  J Hand Surg Br       Date:  2006-06-12

8.  Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.

Authors:  Clayton A Peimer; Philip Blazar; Stephen Coleman; F Thomas D Kaplan; Ted Smith; Tommy Lindau
Journal:  J Hand Surg Am       Date:  2015-06-18       Impact factor: 2.230

9.  A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study.

Authors:  Annet L van Rijssen; Feike S J Gerbrandy; Hein Ter Linden; Helen Klip; Paul M N Werker
Journal:  J Hand Surg Am       Date:  2006 May-Jun       Impact factor: 2.230

10.  Percutaneous needle aponeurotomy: complications and results.

Authors:  G Foucher; J Medina; R Navarro
Journal:  J Hand Surg Br       Date:  2003-10
View more
  1 in total

Review 1.  Treatment Options for Dupuytren's Disease: Tips and Tricks.

Authors:  Keith A Denkler; Keon Min Park; Osaid Alser
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-01-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.